This compound is a chiral pharmaceutical intermediate featuring both an epoxide ring and a nitrobenzenesulfonate ester group. Its primary significance lies in its use as a synthetic building block for the preparation of enantiomerically pure pharmaceutical compounds.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 115314-17-5
(S)-(+)-Glycidyl-4-nitrobenzenesulfonate
pharmaceutical intermediate
(R)-(-)-Glycidyl-4-nitrobenzenesulfonate
pharmaceutical intermediate
(3beta)-Androsta-5,16-diene-3,17-diol 3-acetate 17-(trifluoromethanesulfonate)
pharmaceutical intermediate
2-Boc-aminophenylboronic acid
pharmaceutical intermediate
Tert-Butyl 3-(cyanomethylene)azetidine-1-carboxylate
pharmaceutical intermediate
5,6,7,7a-Tetrahydrothieno[3,2-c]pyridine-2(4H)-one hydrochloride
pharmaceutical intermediate
(S)-(+)-Glycidyl nosylate
pharmaceutical intermediate
(R)-glycidyl tosylate
pharmaceutical intermediate
[(2R)-oxiran-2-yl]methyl 3-nitrobenzenesulfonate
AIHIHVZYAAMDPM-MRVPVSSYSA-N
C1[C@@H](O1)COS(=O)(=O)C2=CC=CC(=C2)[N+](=O)[O-]